Increases in circulating matrix metalloproteinase-9 levels following fibrinolysis for acute pulmonary embolism (2010)
- Authors:
- Autor USP: SANTOS, JOSE EDUARDO TANUS DOS - FMRP
- Unidade: FMRP
- DOI: 10.1016/j.thromres.2010.02.015
- Subjects: EMBOLIA PULMONAR; FIBRINÓLISE
- Language: Inglês
- Imprenta:
- Publisher place: Kidlington
- Date published: 2010
- Source:
- Título: Thrombosis Research
- ISSN: 0049-3848
- Volume/Número/Paginação/Ano: v. 125, n. 6, p. 549-553, 2010
- Este periódico é de assinatura
- Este artigo NÃO é de acesso aberto
- Cor do Acesso Aberto: closed
-
ABNT
MÜHL, Diána et al. Increases in circulating matrix metalloproteinase-9 levels following fibrinolysis for acute pulmonary embolism. Thrombosis Research, v. 125, n. 6, p. 549-553, 2010Tradução . . Disponível em: https://doi.org/10.1016/j.thromres.2010.02.015. Acesso em: 02 out. 2024. -
APA
Mühl, D., Ghosh, S., Uzuelli, J. A., Lantos, J., & Tanus-Santos, J. E. (2010). Increases in circulating matrix metalloproteinase-9 levels following fibrinolysis for acute pulmonary embolism. Thrombosis Research, 125( 6), 549-553. doi:10.1016/j.thromres.2010.02.015 -
NLM
Mühl D, Ghosh S, Uzuelli JA, Lantos J, Tanus-Santos JE. Increases in circulating matrix metalloproteinase-9 levels following fibrinolysis for acute pulmonary embolism [Internet]. Thrombosis Research. 2010 ; 125( 6): 549-553.[citado 2024 out. 02 ] Available from: https://doi.org/10.1016/j.thromres.2010.02.015 -
Vancouver
Mühl D, Ghosh S, Uzuelli JA, Lantos J, Tanus-Santos JE. Increases in circulating matrix metalloproteinase-9 levels following fibrinolysis for acute pulmonary embolism [Internet]. Thrombosis Research. 2010 ; 125( 6): 549-553.[citado 2024 out. 02 ] Available from: https://doi.org/10.1016/j.thromres.2010.02.015 - Atorvastatina reduz a hipertensão arterial pulmonar causada por embolia pulmonar aguda (EPA) em ratos
- Enhanced concentrations of relevant markers of nitric oxide formation after exercise training in patients with metabolic syndrome
- Nitric oxide formation is inversely related to serum levels of antiangiogenic factors soluble Fms-like tyrosine kinase-1 and soluble endogline in preeclampsia
- Influence of eNOS haplotypes on the plasma nitric oxide products concentrations in hypertensive and type 2 diabetes mellitus patients
- Interethnic differences in the distribution of clinically relevant vascular endothelial growth factor genetic polymorphisms
- Sildenafil improves the beneficial hemodynamic effects exerted by atorvastatin during acute pulmonary thromboembolism
- Matrix metalloproteinase-9 genetic variation affect MMP-9 levels in obese children
- Sodium nitrite does not inhibit circulating angiotensin converting enzyme activity
- Matrix metalloproteinases as drug targets in preeclampsia
- Quercetin restores plasma nitrite and nitroso species levels in renovascular hypertension
Informações sobre o DOI: 10.1016/j.thromres.2010.02.015 (Fonte: oaDOI API)
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas